financetom
Business
financetom
/
Business
/
What's Going On With Chipotle Stock Thursday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Chipotle Stock Thursday?
Jul 25, 2024 6:47 AM

Chipotle Mexican Grill Inc ( CMG ) shares traded higher before paring gains Thursday morning on the heels of the company’s second-quarter financial results. Here’s what you need to know.

What Happened: After the market close on Wednesday, Chipotle reported second-quarter revenue of $2.97 billion, beating the consensus estimate of $2.94 billion. The company also beat analyst estimates for earnings of 32 cents per share with reported earnings of 34 cents per share.

According to data from Benzinga Pro, Chipotle has now beat estimates on the top and bottom lines in four consecutive quarters.

Comparable restaurant sales increased 11.1% year-over-year driven by over 8% transaction growth as margins expanded. Operating margin was 19.7% in the second quarter, up from 17.2% year-over-year.

Chipotle noted that it repurchased $151.4 million of its stock during the second quarter and said it had $647.7 million remaining under its share repurchase authorization after its board authorized an additional $400 million in repurchases in June.

Chipotle reiterated expectations for full-year 2024 comparable restaurant sales growth in the mid to high single-digit range. The company said it still anticipates opening between 285 and 315 new restaurants in 2024 with over 80% including a Chipotlane.

Check This Out: ‘Markets Are Sounding An Alarm:’ Peter Schiff Warns Federal Reserve Should Cut Rates Before Recession Hits

Analyst Changes: Multiple analysts adjusted price targets on the stock following the print.

Wedbush analyst Nick Setyan maintained Chipotle with a Neutral and lowered the price target from $64 to $54.

Stephens & Co. analyst Jim Salera maintained Chipotle with an Equal-Weight and lowered the price target from $64 to $61.

TD Cowen analyst Andrew Charles maintained Chipotle with a Buy and lowered the price target from $72 to $65.

Piper Sandler analyst Brian Mullan maintained Chipotle with a Neutral and lowered the price target from $61 to $56.

CMG Price Action: Chipotle shares initially climbed more than 13% on the report, before pulling back. The stock was down 0.44% at $51.55 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved